Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Today marks the launch of a new Oxford-wide initiative – the Oxford Centre for Haematology (OCH).

This virtual Centre aims to promote integration between academic and clinical haematology programmes in the University and Oxford University Hospitals NHS Foundation Trust and thereby capitalise on scientific opportunities to transform our understanding of haematopoiesis and blood diseases, with the goal of radically improving patient care.

The OCH will be led by Prof Paresh Vyas, a member of the MRC Molecular Haematology Unit based at the MRC WIMM, and several of the centre’s members are based at our Institute.

OCH builds on over 40 years of haematology research excellence in Oxford. From the pioneering work on globins led by our founder Professor Sir David Weatherall, Prof John Clegg and Prof Doug Higgs, through to our current position of driving the largest blood cancer clinical trials program in the UK, Oxford is truly a powerhouse of haematology research. OCH will build on, and enhance, our understanding of blood cancers, ageing of the haematopoietic system and the links with inflammation and immunity. The Centre will also raise new funding for research, trials and implementation into clinical practice, alongside training the next generation of scientists and healthcare professionalsand encouraging partnerships.

Establishing the Centre has been made possible thanks to funding from the NIHR Oxford Biomedical Research Centre and will be hosted by RDM, embedded within the Nuffield Division of Clinical Laboratory Sciences.

More information can be found here and all are invited to attend the OCH Inaugural Symposium on the 26 March.

Please direct any questions about OCH to Julie Stevens,whose desk is based in the WIMM’s Administration Office.

Similar stories

MRC HIU appoints new Director

MRC HIU RDM

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

Research unpicks why immune responses decrease with age

MRC MHU

Study reveals what happens to blood cell production during the ageing process, which could help identify new therapeutic targets.

Study uncovers how low blood iron diminishes immune response

MRC HIU NDM RDM

The Drakesmith group finds that low blood serum iron levels can inhibit T-cell and B-cell immune responses to vaccines and infections.

Study finds new human blood disorder

MRC MHU RDM

The Patel Group have discovered a new human disease caused by formaldehyde accumulation in cells

Role-playing computer game helps players understand how vaccines work on a global scale

Centre for Computational Biology MRC HIU RDM

A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.